Twitter | Search | |
Search Refresh
Aysun Capci Jul 19
Highlights!! 🙂 🌿 🦟 Deadly parasites succumb to a drug mash-up
Reply Retweet Like
MedChemExpress Jul 16
BRD9185 has activity. BRD9185 is a Dihydroorotate dehydrogenase () inhibitor, with an EC50 of 16 nM against multidrug-resistant blood-stage parasites. .
Reply Retweet Like
Kew Mobile Museum Jun 8
Happy . Fancy a ? Extracted from the bark of the tree, the bitter ingredient in water is . For 350 years, cinchona was a well-respected treatment, prior to the development of synthetic replacements in the 1940s.
Reply Retweet Like
Laurent ARNAUD May 29
The recent recommendations about mention as the main ... so it's nice to check the comparative efficacy of versus for the cutaneous manifestations of ➡️
Reply Retweet Like
Jennifer Primmer PhD Sep 1
Retired General is now calling on the Department of to step up and take responsibility for any or physical side effects caused by the drug,
Reply Retweet Like
The HealthZone 23 Apr 18
You contribute to drug resistance by self-medication with drugs. This means that is becoming resistant to drugs that used to be effective against it because of the indiscriminate use of antimalarial drugs.
Reply Retweet Like
Military Claims UK Jun 20
Ireland: It is “baffling” that Defence Forces personnel are still being prescribed with drug , while the State faces dozens of claims due to alleged side effects of the medicine, the Dáil has heard.
Reply Retweet Like
#PharmaLearning 30 Dec 17
AS REQUESTED: Malaria is a life-threatening but preventable and curable disease. Our summary covers drugs and the aspects that are considered when determining the best malaria prophylaxis option for patients
Reply Retweet Like
Kew Mobile Museum Aug 23
WE NEED YOU! Help transcribe economic botany specimen labels and be part of a fascinating research project on the history of ~ the bitter taste in & the most important historical treatment. More info:
Reply Retweet Like
Franck Dumetz, PhD 🏳️‍🌈🇪🇺 May 1
Catherine Merrick’s team is looking to recruit a new to work on “Repositioning G-quadruplex-binding agents as drugs” apply by 31/05 ⁦⁦⁩ ⁦⁦⁦
Reply Retweet Like
Bug Off! Apr 26
We're excited to be at tonight at from 6pm. Pop by the Bug Off! stand and test your attractiveness to our , learn about drugs and discover the latest research! More info at:
Reply Retweet Like
Malariagreenleaf 23 Nov 17
Meeting District leaders of Kabarole today. Together, we pave ways of how to get our people aware about fighting malaria, testing&treating using readily available price subsidized ACTs with a symbol.
Reply Retweet Like
Malariagreenleaf 23 Nov 17
In Kisawo Village of Kayunga District, we sat down with family heads and we chatted about strategies to . We gave them the good news about availability of cheap&affordable drugs, ACTs that bear a greenleaf symbol on the box
Reply Retweet Like
traveljab.co.uk May 13
medication can reduce the risk of getting by approximately 90%. A short trial course of antimalarial tablets may be required before . This is to ensure that medication was suited and no side effects occurred. Learn more:
Reply Retweet Like
Charles Narh 3 Jul 18
Using data to inform interventions in the sub-region. How genotyping can help predict the parasite sensitivity to Crucial for ⁩ ⁦
Reply Retweet Like
Military Claims UK Feb 25
CANADA: Countless soldiers suffered terrible side-effects in 'botched clinical trial'
Reply Retweet Like
SequentiaBiotech 18 Jun 18
Andrés trying not to get lost amongst our plants! Now over 3m long!! Optimized , 100% natural source of and twice the standard in planta concentration. and more!
Reply Retweet Like
Malariagreenleaf 24 Nov 17
At Kyenjojo district, we met with the leadership to pave strategies on how to popularize the campaign to get communities aware of the availability of price subsidized drugs, ACTs bearing a symbol
Reply Retweet Like
Ray Griggs 4 Feb 16
Need more info on drugs in ? This new resource should help -
Reply Retweet Like
CreekLab Jun 5
Our latest review discussing ozonide activity in the context of artemisinin-resistant has just been published in Will the extended half-life of OZ439 translate to improved clinical activity against artemisinin-resistant ?
Reply Retweet Like